This inventor holds 2 USPTO granted patents. Top assignee: Sterling Drug Inc.. Active years: 1979-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979-1982
Title: Edward D. Parady: Innovator in Chemical Processes
Introduction
Edward D. Parady is a notable inventor based in Schodack, NY (US). He has made significant contributions to the field of chemistry, particularly in the development of innovative processes for synthesizing important chemical compounds. With a total of 2 patents to his name, Parady's work has implications in various applications, including pharmaceuticals.
Latest Patents
Parady's latest patents include a process for the low-temperature, aqueous conversion of 4-picoline derivatives. This process involves reacting 4-picoline with inorganic acid halides, such as phosphorus oxychloride, and excess dimethylformamide. The resulting compound, N-[3-dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium salt, is further processed to isolate 5-cyano-[3,4'-bipyridin]-6(1H)-one, which serves as an intermediate for preparing the cardiotonic amrinone. Another significant patent involves the morphine/apomorphine rearrangement process, which enhances the yield of apomorphine derivatives through the rearrangement of morphine derivatives in the presence of anhydrous orthophosphoric acid.
Career Highlights
Edward D. Parady has had a distinguished career, working at Sterling Drug Inc., where he has been able to apply his innovative ideas in a practical setting. His expertise in chemical processes has allowed him to contribute to advancements in the pharmaceutical industry.
Collaborations
Throughout his career, Parady has collaborated with notable colleagues, including Roman R. Lorenz and William H. Thielking. These collaborations have further enriched his work and contributed to the success of various projects.
Conclusion
Edward D. Parady's contributions to chemical processes and his innovative patents highlight his role as a significant figure in the field. His work continues to influence the development of important pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
